New, but Not Improved? Incorporating Comparative-Effectiveness Information Into FDA Labeling

N Engl J Med. 2009 Sep 24;361(13):1230-3. doi: 10.1056/NEJMp0906490. Epub 2009 Aug 12.

MeSH terms

  • Cost-Benefit Analysis
  • Drug Labeling / legislation & jurisprudence*
  • Drug Labeling / trends
  • Government Regulation*
  • Health Services Research
  • Humans
  • Therapeutic Equivalency*
  • Treatment Outcome
  • United States
  • United States Food and Drug Administration*